Delivery Order SPE2DR25D3306-SPE2DR26F5F2V
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with a contract value of $4,194.48. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. This delivery...
- The Defense Logistics Agency awarded a $8,745.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 5 mg/0.5 ml pens. The contract, which has no set-aside designation, is scheduled for completion by December 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on December 3, 2025, with a ceiling value of $2,583.98 and an ultimate completion date of December 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $44,636.86 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pens on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $3,053.36 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on November 25, 2025, with completion expected by November 26, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance fulfillment at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $11,125.18 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 18, 2025, and performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on October 17, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with a ceiling value of approximately $14.8K. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 20, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,123.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on November 12, 2025, with completion expected by November 13, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $6,340.16 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on December 9, 2025, with an ultimate completion date of December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens valued at $12,186.12, with completion scheduled for December 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- SPE2DR25D3306Indefinite Delivery Contract
- SPE2DR25D3306-SPE2DR26F5F2VDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,973.55 to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively made. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. Zepbound, a diabetes medication, aligns with AmerisourceBergen's established track record of delivering specialty medications and brand-name drugs to support the Defense Health Agency and other federal healthcare systems through its global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 12/11/25 |